The Short Answer: Cure Depends on When You Got Infected

Most adults who catch hepatitis B clear the virus on their own within six months without any treatment. Your immune system defeats it, and you develop lifelong immunity. But about 5 to 10 percent of infected adults cannot clear the virus and develop chronic hepatitis B—a long-term infection that persists for life.

There is currently no cure for chronic hepatitis B. However, antiviral medications can suppress the virus to undetectable levels, stop liver damage, and let you live a normal lifespan. The difference between "cured" and "controlled" matters: you remain infected and can transmit the virus, but the infection no longer harms your liver or your health.

Key Takeaways

  • Most adults clear acute hepatitis B on their own; only 5 to 10 percent develop the chronic form that requires lifelong management.
  • Antiviral drugs like tenofovir and entecavir can reduce the virus to undetectable levels and stop liver scarring, but they do not eliminate the virus entirely.
  • People with chronic hepatitis B who take antivirals as prescribed have life expectancies equal to people without the virus.
  • Stopping antiviral treatment usually causes the virus to rebound, so these medications are typically taken indefinitely.
  • Liver transplantation is an option only for people whose livers have failed from advanced cirrhosis, not a cure for the infection itself.

Why Some People Clear the Virus and Others Don't

Whether your body defeats hepatitis B depends largely on your age when you were infected. Adults who catch it have a 90 to 95 percent chance of clearing it within months. Infants and young children have the opposite pattern: 90 percent of infected infants develop chronic infection because their immune systems are still developing and do not recognize the virus as a threat.

Other factors that influence whether you clear the virus include your sex (women clear it more often than men), your overall immune health, and the specific strain of hepatitis B you contracted. Some people also have genetic variations that affect how their immune system responds. But age at infection is the strongest predictor.

How Antiviral Medications Work and What They Achieve

Antiviral drugs for hepatitis B work by blocking the enzyme the virus uses to copy itself. The two most commonly prescribed are tenofovir and entecavir. When you take them as directed, the virus cannot replicate, and the amount of virus in your blood drops to levels that blood tests cannot detect.

This matters because undetectable virus means the infection is not actively damaging your liver. Studies show that people on antivirals who maintain undetectable viral loads do not develop new scarring and often see existing scarring stabilize or improve. Your liver function can remain normal for decades.

However, the virus itself remains in your liver cells. If you stop taking the medication, the virus begins replicating again within weeks or months. This is why hepatitis B treatment is typically lifelong—not because the drug cures the infection, but because stopping it allows the virus to return.

Life Expectancy and Long-Term Outcomes With Treatment

People with chronic hepatitis B who start antivirals before their liver is severely damaged and who take the medication consistently have life expectancies that match the general population. This is one of the major advances in hepatitis B care over the past 15 years: the infection has shifted from a progressive disease that eventually causes liver failure to a manageable chronic condition.

The key is starting treatment early and staying on it. People who delay treatment until cirrhosis develops face a higher risk of liver cancer and liver failure, even after starting antivirals. Regular monitoring with blood tests and ultrasound or elastography (a test that measures liver stiffness) helps catch changes early.

Why Researchers Haven't Found a Cure Yet

Hepatitis B is difficult to cure because the virus integrates into your liver cell DNA in a way that is hard to target without harming the cells themselves. Researchers are exploring several approaches—including immunotherapy to boost your immune system's ability to recognize infected cells, and gene-editing techniques—but none have yet moved into widespread clinical use.

A small number of people have been cured through a combination of experimental treatments, usually involving stem cell transplants or gene therapy, but these are not standard options. Most hepatitis B research now focuses on making lifelong antiviral treatment simpler (fewer pills, less frequent dosing) rather than finding a cure.

Liver Transplantation: When It's Considered and What It Means

Liver transplantation is an option only for people whose livers have failed from advanced cirrhosis—not a treatment for hepatitis B itself. If your liver is failing, a transplant can save your life. However, the hepatitis B virus will infect the new liver unless you take preventive measures.

People who receive a liver transplant for hepatitis B-related failure take antivirals and hepatitis B immunoglobulin (a concentrated antibody) to prevent the virus from infecting the new organ. With these precautions, transplanted livers can function well for many years. But transplantation is a major surgery with its own risks and requires lifelong immunosuppression to prevent rejection.

What "Functional Cure" Means and Why It Matters

Researchers sometimes use the term functional cure to describe a state where the virus is suppressed so completely that it causes no detectable harm and cannot be transmitted sexually or through blood exposure. This is different from a sterilizing cure, which would eliminate the virus entirely.

A functional cure is what antivirals currently achieve for most people who take them consistently. The virus is still present in your liver, but it is not replicating, not damaging tissue, and not transmissible. For practical purposes—your health, your lifespan, your ability to work and live normally—a functional cure is what matters.

Frequently Asked Questions

If I have chronic hepatitis B, do I have to take antivirals forever?

Most people with chronic hepatitis B take antivirals indefinitely because stopping them usually allows the virus to rebound. However, some people with low viral loads and no signs of liver damage may be monitored without treatment. Your doctor will assess your individual situation based on blood tests and liver imaging.

Can I transmit hepatitis B to others if I'm on antivirals and undetectable?

Sexual transmission risk is extremely low when viral load is undetectable, though some guidelines still recommend barrier protection. Blood-to-blood transmission is also very unlikely. However, you should still inform sexual partners and healthcare providers of your status, and pregnant women should take precautions to prevent transmission to their baby.

What happens if I miss doses of my hepatitis B medication?

Missing occasional doses usually does not cause immediate problems, but missing doses regularly can allow the virus to rebound and develop resistance to the drug. If you struggle with taking medication consistently, talk to your doctor about options like longer-acting injections or simplified regimens.

Is there a difference between acute and chronic hepatitis B treatment?

Acute hepatitis B typically does not require antiviral treatment—your immune system handles it. Chronic hepatitis B requires antivirals to suppress the virus and prevent liver damage. Your doctor will determine which type you have based on blood tests and how long the infection has lasted.

Can lifestyle changes cure hepatitis B?

Diet, exercise, and avoiding alcohol cannot cure hepatitis B, but they support liver health and reduce the risk of additional liver damage. Avoiding alcohol is especially important because it accelerates liver scarring in people with chronic hepatitis B. Antivirals remain the only treatment that controls the virus itself.